Two routes to the same protein
The distinction is a matter of pretreatment. Type A gelatin is produced by acid treatment of collagen, typically over a short conditioning period. Type B is produced by alkaline treatment, which takes considerably longer. Both yield gelatin, but the two routes leave the protein with different charge characteristics, and that difference propagates into how each behaves in a finished formulation.
The isoelectric point is the practical difference
Every gelatin carries a pH at which its net charge is zero. For Type A this sits in the alkaline region; for Type B it sits on the acid side. Near that point the protein is least soluble and most prone to haze or precipitation. Knowing where your formulation's pH sits relative to the isoelectric point of the grade explains most clarity and stability problems that otherwise look inexplicable.
Charge interactions with other ingredients
Because the two types carry opposite net charge across much of the usable pH range, they interact differently with charged ingredients. Anionic hydrocolloids, certain colours and some actives will associate with one type and remain indifferent to the other. Where a formulation contains charged components, substituting one type for another is a reformulation rather than a like-for-like swap.
Bovine sourcing and what it implies
Bovine hide and bone are commonly processed by the alkaline route, so bovine gelatin frequently arrives as Type B, though acid-processed bovine material is also produced. The type is a consequence of processing, not of the animal, and should be confirmed against the specification rather than assumed from the raw material. Halal status is likewise a question of sourcing and control, independent of type.
Where the choice genuinely matters
In neutral, low-ionic-strength systems the two types often perform interchangeably and selection can be driven by availability and price. The choice becomes critical in acidified products, in clear systems where haze is unacceptable, and wherever charged polymers are present. These are the applications in which a change of type produces effects no adjustment of dosage will correct.
Fix the type in the specification
Record the required type alongside Bloom, viscosity and mesh, and treat a proposed change as a formulation trial rather than a procurement decision. Confirming the type at qualification and holding it in the specification prevents a substitution that looks equivalent on paper from arriving as a clarity or texture failure in production.
Record the required type alongside Bloom, viscosity and mesh, and treat a proposed change as a formulation trial rather than a procurement decision. Confirming the type at qualification and holding it in the specification prevents a substitution that looks equivalent on paper from arriving as a clarity or texture failure in production.
